Risk of febrile neutropenia in patients receiving emerging chemotherapy regimens.

Publication Type:

Journal Article


Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2014)


2014, August 2014, Center-Authored Paper, Institute for Cancer Outcomes Research and Evaluation (ICORE)


Considerable evidence exists concerning the risk of febrile neutropenia (FN) associated with well-established, older chemotherapy regimens. Little is known, however, about the risks associated with many regimens that were introduced in the past decade and have become the predominant choice for certain cohorts of patients or are increasingly being used in clinical practice.